The aim of this study was to assess percentage respiratory changes (δ) in the size of pulmonary cysts of different smoking-related etiologies. Retrospectively, we measured the cystic lesions due to histopathological-confirmed honeycombing from interstitial pulmonary fibrosis, pulmonary Langerhans cell histiocytosis (PLCH), and paraseptal emphysema, using paired inspiratory and expiratory CT scans. In a sample of 72 patients and 216 lesions, the mean diameter of PLCH and honeycombing decreased during expiration (PLCH, δ = 60.9%; p = 0.001; honeycombing, δ = 47.5%; p = 0.014). Conversely, paraseptal emphysema did not show any changes (δ = 5.2%; p = 0.34). In summary, our results demonstrated that cysts in smokers with PLCH and honeycombing fibrosis get smaller during expiratory CT scans, whereas the size of cystic-like lesions due to paraseptal emphysema and bullae tend to remain constant during respiratory cycles. These results support the hypothesis of cyst-airway communication in some cystic diseases, which could assist in the differential diagnosis in smoking-related lung diseases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00408-022-00576-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Paraseptal Lucencies Mimicking Emphysema in a Non-smoker With Acute Lung Injury in COVID-19.
Cureus
October 2024
Cardiothoracic Imaging, University of Texas Southwestern Medical Center, Dallas, USA.
Paraseptal emphysema can be smoking-related but has other causes, including surfactant deficiency, COVID-19, and age. The typical acute chest tomographic findings of COVID-19 include bilateral ground-glass opacities with or without consolidation and interstitial thickening in a peripheral and posterior predominant distribution. Evolution of these findings can occur and ultimately lead to fibrosis.
View Article and Find Full Text PDFSilent Vanishing Lung Syndrome: Severe Emphysema in an Asymptomatic Patient.
Cureus
August 2024
Department of Psychiatry, Larkin Community Hospital, South Miami, USA.
Vanishing lung syndrome (VLS) is an uncommon condition characterized by idiopathic giant bullous emphysema, resulting in the lungs appearing abnormally small on radiological scans. Some case reports have suggested a potential association between the development of this condition in young males, individuals with a history of heavy tobacco smoking, methamphetamine, and marijuana use, and those previously diagnosed with HIV. The primary diagnostic tools for vanishing lung syndrome include initial x-rays and high-resolution CT scans, which play a crucial role in confirming the diagnosis.
View Article and Find Full Text PDFAnesthetic management of a case of a lip mass with paraseptal emphysema and multiple bilateral giant bullae for surgical resection under mental nerve block.
Saudi J Anaesth
June 2024
Department of Anesthesiology and Critical Care, GNRC Medical, North Guwahati, Assam, India.
Anesthesia in patients with emphysematous giant bulla undergoing non-thoracic surgery is challenging and can cause serious complications. We report a successful case of lip mass resection in a 65-year-old male with paraseptal emphysema and giant bullae under regional anesthesia using a mental nerve block. The patient presented with a slow-growing ulcerative mass on his lower lip and had a history of non-compliant COPD management.
View Article and Find Full Text PDFAnalysis of clinical characteristics and prognosis of lung cancer patients with CPFE or COPD: a retrospective study.
BMC Pulm Med
June 2024
Department of Respiratory Medicine, The First Affiliated Hospital, College of Medicine, Zhejiang University, No.79, Qingchun Road, Hangzhou, Zhejiang, China.
Background: Lung cancer (LC) commonly occurs in patients with combined pulmonary fibrosis and emphysema (CPFE) and chronic obstructive pulmonary disease (COPD), but comparative research is limited. This study examines clinical characteristics, treatments, and prognosis in LC patients with CPFE or COPD.
Methods: The retrospective study involved 75 lung cancer patients with CPFE and 182 with COPD.
Central Role of CT in Management of Pulmonary Fibrosis.
Radiographics
June 2024
From the Department of Radiology, Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Republic of Korea (K.J.C.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea (H.J.H.); and Department of Radiology (K.J.C., S.M.H., S.K., D.A.L.) and Department of Medicine, Divisions of Pathology (R.D.A.) and Pulmonary and Critical Care Medicine (J.C.C.), National Jewish Health, 1400 Jackson St, Denver, CO 80206.
With the approval of antifibrotic medications to treat patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis, radiologists have an integral role in diagnosing these entities and guiding treatment decisions. CT features of early pulmonary fibrosis include irregular thickening of interlobular septa, pleura, and intralobular linear structures, with subsequent progression to reticular abnormality, traction bronchiectasis or bronchiolectasis, and honeycombing. CT patterns of fibrotic lung disease can often be reliably classified on the basis of the CT features and distribution of the condition.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!